Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Letrozole in the treatment of severe and recurrent endometriosis.

Trial Profile

Letrozole in the treatment of severe and recurrent endometriosis.

Completed
Phase of Trial: Phase II

Latest Information Update: 25 Apr 2012

At a glance

  • Drugs Gonadotropin releasing hormone stimulants; Letrozole
  • Indications Endometriosis
  • Focus Therapeutic Use
  • Most Recent Events

    • 31 Aug 2018 Biomarkers information updated
    • 25 Apr 2012 Actual end date (June 2006) added as reported by ClinicalTrials.gov.
    • 05 Jul 2007 Status changed from in progress to completed.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top